Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins

Currently, chondroitin sulfate (CS) and hyaluronic acid (HA) pharma-grade forms are used for osteoarthritis (OA) management, CS as an oral formulations component, and HA as intra-articular injective medical devices. Recently, unsulfated chondroitin, obtained through biofermentative (BC) manufacturin...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassallo, Valentina, Di Meo, Celeste, Toro, Giuseppe, Alfano, Alberto, Iolascon, Giovanni, Schiraldi, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610477/
https://www.ncbi.nlm.nih.gov/pubmed/37895900
http://dx.doi.org/10.3390/ph16101429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610477/
https://www.ncbi.nlm.nih.gov/pubmed/37895900
http://dx.doi.org/10.3390/ph16101429

Ejemplares similares